ProfileGDS2971 / 8.3.5.3
TitleHemiasterlin analog HTI-286 effect on docetaxel-resistant prostate cancer cell line
OrganismHomo sapiens


HTI-286 docetaxel GSM206100 GSM206166 GSM206167 GSM206168 GSM206169 GSM206170 GSM206357 GSM206358 GSM206359 GSM206360 GSM206361 GSM206362 46% 53% 48% 32% 85% 80% 35% 63% 76% 40% 69% 16% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM206100HTI-286 in docetaxel-refractory prostate cancer (Biological Replicate 1)-0.023802146
GSM206166HTI-286 in docetaxel-refractory prostate cancer (Dye Flip 1)0.1002553
GSM206167HTI-286 in docetaxel-refractory prostate cancer Biological Replicate 2-0.013136848
GSM206168HTI-286 in docetaxel-refractory prostate cancer (Biological Replicate 3)-0.27368432
GSM206169HTI-286 in docetaxel-refractory prostate cancer (Dye flip2)0.64108585
GSM206170HTI-286 in docetaxel-refractory prostate cancer (dyeflip3)0.4877980
GSM206357HTI-286 in docetaxel-refractory prostate cancer_docet (Dye flip1)-0.16390235
GSM206358HTI-286 in docetaxel-refractory prostate cancer_docet (Biological Replicate1)0.19029663
GSM206359HTI-286 in docetaxel-refractory prostate cancer_docet (Dye flip2)0.44565476
GSM206360HTI-286 in docetaxel-refractory prostate cancer_docet (Biological Replicate2)-0.11503240
GSM206361HTI-286 in docetaxel-refractory prostate cancer_docet (Dye flip3)0.34346169
GSM206362HTI-286 in docetaxel-refractory prostate cancer_docet (Biological Replicate3)-0.69984716